Exact Mass: 378.0685672

Exact Mass Matches: 378.0685672

Found 46 metabolites which its exact mass value is equals to given mass value 378.0685672, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid

3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid

C17H14O10 (378.05869440000004)


3,4,5-trihydroxy-6-({7-oxo-7h-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 4-hydroxy-7h-furo[3,2-g]chromen-7-one. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

Enterolactone 3'-sulfate

(3-{[(3S,4S)-4-[(3-hydroxyphenyl)methyl]-2-oxooxolan-3-yl]methyl}phenyl)oxidanesulphonic acid

C18H18O7S (378.07731980000005)


   

Enterolactone 3'-sulfate

(3-{[(3S,4S)-4-[(3-hydroxyphenyl)methyl]-5-oxooxolan-3-yl]methyl}phenyl)oxidanesulphonic acid

C18H18O7S (378.07731980000005)


   

6-Bromo-1-ethoxy-1,8-dihydroaplysinopsin

(+)-6-Bromo-1-ethoxy-1,8-dihydroaplysinopsin

C16H19BrN4O2 (378.06912939999995)


   

Taiwanin E methyl ether

Taiwanin E methyl ether

C21H14O7 (378.0739494)


   

Phellifuropyranone A

Phellifuropyranone A

C21H14O7 (378.0739494)


   
   

Anastatin A

(2S) -2,3-Dihydro-5,7,8-trihydroxy-2- (4-hydroxyphenyl) -4H-Benzofuro [ 3,2-g ] -1-benzopyran-4-one

C21H14O7 (378.0739494)


   

anastatin B

(2S)-2,3-Dihydro-5,9,10-trihydroxy-2-(4-hydroxyphenyl)-4H-benzofuro[2,3-h]-1-benzopyran-4-one

C21H14O7 (378.0739494)


   

Jusmicranthin methyl ether

Jusmicranthin methyl ether

C21H14O7 (378.0739494)


   
   

Justicidin G

Justicidin G

C21H14O7 (378.0739494)


Annotation level-1

   
   
   
   
   

jusmicranthin methyl ester|jusmicranthin methyl ether

jusmicranthin methyl ester|jusmicranthin methyl ether

C21H14O7 (378.0739494)


   
   
   
   

5-(3,4-Dimethoxyphenyl)naphtho[2,3-d]-1,3-dioxole-6,7-dicarboxylic anhydride

5-(3,4-Dimethoxyphenyl)naphtho[2,3-d]-1,3-dioxole-6,7-dicarboxylic anhydride

C21H14O7 (378.0739494)


   

Ala-Phe4Cl-OH

(S)-3-(4-chlorophenyl)-2-(3-methoxy-4-nitrobenzamido)propanoic acid

C17H15ClN2O6 (378.06186)


   

Phe4Cl-Ala-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)propanoic acid

C17H15ClN2O6 (378.06186)


   
   

Thiazolidine, 3-[(4-methyl-3-nitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(4-methyl-3-nitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C17H18N2O4S2 (378.0707948)


   

3-(4-Bromo[1,1-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthalenol

3-(4-Bromo[1,1-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthalenol

C22H19BrO (378.0619184)


   

3,3-CARBONYLBIS(7-METHOXYCOUMARIN)

3,3-CARBONYLBIS(7-METHOXYCOUMARIN)

C21H14O7 (378.0739494)


   

Vortioxetine hydrobromide

Vortioxetine (Lu AA21004) HBr

C18H23BrN2S (378.0765218)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Vortioxetine hydrobromide is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.

   
   

(3,5-bis(trifluoromethyl)phenyl)(3,4-dimethoxyphenyl)methanone

(3,5-bis(trifluoromethyl)phenyl)(3,4-dimethoxyphenyl)methanone

C17H12F6O3 (378.0690594)


   

Laquinimod sodium

Laquinimod sodium

C19H16ClN2NaO3 (378.0747096)


C308 - Immunotherapeutic Agent

   

2-[[3-(4-Methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetic acid ethyl ester

2-[[3-(4-Methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetic acid ethyl ester

C17H18N2O4S2 (378.0707948)


   
   
   

1-(4-Acetylphenyl)-3-[(4-nitrophenyl)sulfonylamino]urea

1-(4-Acetylphenyl)-3-[(4-nitrophenyl)sulfonylamino]urea

C15H14N4O6S (378.06340240000003)


   
   

(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-tert-butylsulfonylprop-2-enenitrile

(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-tert-butylsulfonylprop-2-enenitrile

C17H18N2O4S2 (378.0707948)


   

N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide

N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide

C17H18N2O4S2 (378.0707948)


   

5-fluoro-3-[(4-methoxyphenyl)sulfonylamino]-1H-indole-2-carboxylic acid methyl ester

5-fluoro-3-[(4-methoxyphenyl)sulfonylamino]-1H-indole-2-carboxylic acid methyl ester

C17H15FN2O5S (378.0685672)


   

3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid

3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid

C17H14O10 (378.05869440000004)


   

10-(7-methoxy-2h-1,3-benzodioxol-5-yl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one

10-(7-methoxy-2h-1,3-benzodioxol-5-yl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one

C21H14O7 (378.0739494)


   

8,13,14-trihydroxy-4-(4-hydroxyphenyl)-3,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),8,11(16),12,14-hexaen-6-one

8,13,14-trihydroxy-4-(4-hydroxyphenyl)-3,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),8,11(16),12,14-hexaen-6-one

C21H14O7 (378.0739494)